Quantcast

Valensa Introduces Flex Pro ES(TM) Astaxanthin Gummy for Joint Health

May 6, 2014

Advanced Formula Brings Together Astaxanthin Plus 3 Ingredients for Joint Support

ORLANDO, Fla., May 6, 2014 /PRNewswire/ – Valensa International announced that it has launched and is shipping a new joint health gummy based on its existing Flex Pro ES(TM) joint health product, previously only available in capsules. Flex Pro ES Gummy was developed to provide near- and long-term joint health support using Inulin plus four potent joint health ingredients – Zanthin(®) Natural Astaxanthin, BiovaFlex(TM) Water-Soluble Egg Shell Membrane, Boswellia and a proprietary form of Hyaluronic acid. The patent-pending formula avoids using chondroitin and glucosamine/MSM, which have questionable efficacy, a high pill burden and can cause swallowing difficulties. The naturally flavored joint health gummy has excellent “mouth feel” and taste, is sugar-free, non-GMO, and is also gluten-free. Recommended usage is 3 gummies per day to support joint health and consuming up to 6 gummies per day is acceptable. The product will be licensed to select marketing companies in a number of consumer channels.

According to Dr. Rudi E. Moerck, President & CEO of Valensa, the success of Flex Pro ES capsules as a joint health formula led to the development of a gummy form product. “Flex Pro ES has been one of the most successful formulated products at Valensa. We felt that we could provide the benefits of Flex Pro ES to a wider range of consumers by extending it to this delivery form,” he said. “In developing this gummy, we tackled what we felt were the drawbacks of typical gummy products and utilized Inulin plus organic Stevia in place of sugar – addressing people who are interested in blood sugar health – and also avoiding GMO and soy ingredients,” he said. “The taste is designed to appeal to the adult palate. Flex Pro ES Gummy provides the same dose of natural ingredients as the capsule form, something fairly rare in adult gummy products,” he added.

Astaxanthin Plus Three Additional Functional Ingredients Provide Joint Health Advantages

Flex Pro ES is a comprehensive alternative to chondroitin- and glucosamine-based products for joint health. Valensa believes that consumers who have not found relief with glucosamine and chondroitin containing products will be pleasantly surprised by the great taste of Flex Pro ES Gummies as well as the joint comfort attainable with this product.

The new gummy contains the potent antioxidant Zanthin(®) Natural Astaxanthin. Astaxanthin is known to suppress the production of known inflammatory markers in humans such as TNF-alpha, and prostaglandin E-2 and inhibits nitric oxide synthase (NOS) expression of nitric acid production.

BiovaFlex(TM) is an all-natural ingredient, rich in elastin, collagen and glycosaminoglycans, designed to support the stability and flexibility of joints. Human clinical trials have indicated that this ingredient alone produces positive and statistically significant results within 30 days, including functional flexibility improvement and reduction in joint discomfort.

Boswellia is an Ayurveda herb associated with reduced inflammation. Its properties are associated with boswellic acid, a known 5-lipoxygenase (5-LOX) inhibitor with documented anti-inflammatory properties. Published research suggests that boswellia may also improve the structure of cartilage.

Additional performance is provided by a proprietary Hyaluronic acid (HA), which is the major hydrodynamic component of joint synovial fluid, providing lubrication and shock absorbance. Additionally, anti-inflammatory properties of HA mitigate activities of pro-inflammatory mediators, stimulate immune response and may reduce overall inflammation. The HA used in this formula is produced by fermentation.

For further information contact:
Dr. Rudi Moerck, President & CEO
Voice: 210-632-0695
Fax: 352-483-2095
www.valensa.com

Read more news from Valensa International.

SOURCE Valensa International


Source: PR Newswire



comments powered by Disqus